Literature DB >> 18505787

Species differences in UDP-glucuronosyltransferase activities in mice and rats.

Hirotada Shiratani1, Miki Katoh, Miki Nakajima, Tsuyoshi Yokoi.   

Abstract

UDP-glucuronosyltransferases (UGTs), expressed in various tissues including liver and intestine, catalyze phase II metabolic biotransformation. There is little information on species differences between mice and rats in UGT activities, especially in intestine. The purpose of the present study was to clarify the species differences between mice and rats in UGT activities using duodenal and liver microsomes. For estradiol 3-O-glucuronidation in duodenal microsomes, the kinetic data in mice were fit to the Hill equation. However, the Hill coefficient was low in rats (n = 1.1), suggesting that rat estradiol 3-O-glucuronidation followed the Michaelis-Menten equation rather than the Hill equation. For 4-nitrophenol (4-NP) O-glucuronidation, the K(m) values were different between mice and rats. The intrinsic clearance (CL(int)) values for mycophenolic acid (MPA) O- and morphine 3-O-glucuronidation in male mouse duodenum were 3- and 17-fold lower than those in rat, respectively. In male liver, the CL(int) values for 4-NP O-, propofol O-, MPA O-, and morphine 3-O-glucuronidation and the CL(max) value for 4-methylumbelliferone O-glucuronidation in mice were higher than those in rats. The CL(max) value for estradiol 3-O-glucuronidation in mice was lower than that in rats. Also, there were strain differences among C57BL/6J, BALB/c, C3H/HeJ, DBA/2, ddY, and ICR mice in UGT activities in duodenum. We clarified that the species differences in UGT activity evaluated by the CL(int) or CL(max) values in liver and duodenum varied according to the substrate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505787     DOI: 10.1124/dmd.108.021469

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  14 in total

1.  In vitro glucuronidation of the antibacterial triclocarban and its oxidative metabolites.

Authors:  N H Schebb; B Franze; R Maul; A Ranganathan; B D Hammock
Journal:  Drug Metab Dispos       Date:  2011-09-27       Impact factor: 3.922

2.  Glucuronidation of drugs and drug-induced toxicity in humanized UDP-glucuronosyltransferase 1 mice.

Authors:  Yuki Kutsuno; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Drug Metab Dispos       Date:  2014-04-24       Impact factor: 3.922

3.  Stable isotope-labelled morphine to study in vivo central and peripheral morphine glucuronidation and brain transport in tolerant mice.

Authors:  Ivan Weinsanto; Alexis Laux-Biehlmann; Jinane Mouheiche; Tando Maduna; François Delalande; Virginie Chavant; Florian Gabel; Pascal Darbon; Alexandre Charlet; Pierrick Poisbeau; Marc Lamshöft; Alain Van Dorsselaer; Sarah Cianferani; Marie-Odile Parat; Yannick Goumon
Journal:  Br J Pharmacol       Date:  2018-08-31       Impact factor: 8.739

4.  Contribution of rat intestinal metabolism to the xenobiotics clearance.

Authors:  Mahmud Kajbaf; Raffaella Ricci; Serenella Zambon; Stefano Fontana
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-06-20       Impact factor: 2.441

5.  Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin.

Authors:  Alex E Grill; Brenda Koniar; Jayanth Panyam
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

Review 6.  Species differences in drug glucuronidation: Humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans.

Authors:  Ryoichi Fujiwara; Emiko Yoda; Robert H Tukey
Journal:  Drug Metab Pharmacokinet       Date:  2017-10-07       Impact factor: 3.614

7.  Comparative toxicokinetics of Trans-resveratrol and its major metabolites in Harlan Sprague Dawley rats and B6C3F1/N mice following oral and intravenous administration.

Authors:  Esra Mutlu; Seth T Gibbs; Natalie South; Jessica Pierfelice; Brian Burback; Dori Germolec; Suramya Waidyanatha
Journal:  Toxicol Appl Pharmacol       Date:  2020-03-20       Impact factor: 4.219

8.  PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis.

Authors:  Xueyan Zhou; Lijuan Cao; Changtao Jiang; Yang Xie; Xuefang Cheng; Kristopher W Krausz; Yunpeng Qi; Lu Sun; Yatrik M Shah; Frank J Gonzalez; Guangji Wang; Haiping Hao
Journal:  Nat Commun       Date:  2014-09-03       Impact factor: 14.919

9.  Glucuronidation of drugs in humanized UDP-glucuronosyltransferase 1 mice: Similarity with glucuronidation in human liver microsomes.

Authors:  Yuki Kutsuno; Kyohei Sumida; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Pharmacol Res Perspect       Date:  2013-09-03

10.  Histone acetylation at the sulfotransferase 1a1 gene is associated with its hepatic expression in normal aging.

Authors:  Mohamad M Kronfol; Sara Abudahab; Mikhail G Dozmorov; Fay M Jahr; Matthew S Halquist; MaryPeace McRae; Dayanjan S Wijesinghe; Elvin T Price; Patricia W Slattum; Joseph L McClay
Journal:  Pharmacogenet Genomics       Date:  2021-12-01       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.